Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4200PDF: 1703HTML: 1094 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3144PDF: 900HTML: 2923 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3494PDF: 834HTML: 6693 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1289HTML: 362PDF: 789 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1548PDF: 719HTML: 223 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1232PDF: 770HTML: 112 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1160PDF: 731HTML: 296 -
-
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1687PDF: 929HTML: 126 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1865PDF: 703HTML: 677
1 - 14 of 14 items







